ATE79633T1 - Verfahren zur herstellung des alpha-1-proteinase- inhibitors. - Google Patents

Verfahren zur herstellung des alpha-1-proteinase- inhibitors.

Info

Publication number
ATE79633T1
ATE79633T1 AT86114461T AT86114461T ATE79633T1 AT E79633 T1 ATE79633 T1 AT E79633T1 AT 86114461 T AT86114461 T AT 86114461T AT 86114461 T AT86114461 T AT 86114461T AT E79633 T1 ATE79633 T1 AT E79633T1
Authority
AT
Austria
Prior art keywords
alpha
proteinase inhibitor
resin
manufacture
aqueous solution
Prior art date
Application number
AT86114461T
Other languages
English (en)
Inventor
Michael H Coan
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Application granted granted Critical
Publication of ATE79633T1 publication Critical patent/ATE79633T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S210/00—Liquid purification or separation
    • Y10S210/902—Materials removed
    • Y10S210/903—Nitrogenous
    • Y10S210/905—Protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT86114461T 1985-11-01 1986-10-18 Verfahren zur herstellung des alpha-1-proteinase- inhibitors. ATE79633T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/793,807 US4697003A (en) 1985-11-01 1985-11-01 Method of preparing alpha-1-proteinase inhibitor
EP86114461A EP0221426B1 (de) 1985-11-01 1986-10-18 Verfahren zur Herstellung des alpha-1-Proteinase-Inhibitors

Publications (1)

Publication Number Publication Date
ATE79633T1 true ATE79633T1 (de) 1992-09-15

Family

ID=25160853

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86114461T ATE79633T1 (de) 1985-11-01 1986-10-18 Verfahren zur herstellung des alpha-1-proteinase- inhibitors.

Country Status (8)

Country Link
US (1) US4697003A (de)
EP (1) EP0221426B1 (de)
JP (1) JPH0764750B2 (de)
AT (1) ATE79633T1 (de)
AU (1) AU591397B2 (de)
CA (1) CA1286848C (de)
DE (1) DE3686470T2 (de)
ES (1) ES2051684T3 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
DE3612137A1 (de) * 1986-04-10 1987-10-15 Biotest Pharma Gmbh Steriles plasmaaustauschmittel
US4808314A (en) * 1987-09-18 1989-02-28 Scripps Clinic And Research Foundation Method for reducing bacterial endotoxin contamination in solutions of macromolecules
US5151358A (en) * 1989-06-13 1992-09-29 Genencor International, Inc. Processes for the recovery of naturally produced chymosin
US5139943A (en) * 1989-06-13 1992-08-18 Genencor International, Inc. Processes for the recovery of microbially produced chymosin
US5290474A (en) * 1990-10-05 1994-03-01 Genencor International, Inc. Detergent composition for treating cotton-containing fabrics containing a surfactant and a cellulase composition containing endolucanase III from trichoderma ssp
US5328841A (en) * 1990-10-05 1994-07-12 Genencor International, Inc. Methods for isolating EG III cellulase component and EG III cellulase in polyethylene glycol using inorganic salt and polyethylene glycol
CA2093422C (en) * 1990-10-05 2001-04-03 DETERGENT COMPOSITIONS CONTAINING LOW CBH I CONTENT CELLULASE COMPOSITIONS
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung
US6093804A (en) * 1998-09-24 2000-07-25 American National Red Cross Method for purification of alpha-1 proteinase inhibitor
US6887678B2 (en) * 1998-12-02 2005-05-03 Cindy L. Bristow Method for the quantitative determination of proteinase inhibitors
US6462180B1 (en) 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
NZ526940A (en) 2000-12-14 2005-06-24 Bayer Healthcare Llc Method of preparing alpha-1 proteinase inhibitor
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
ATE391730T1 (de) * 2003-09-22 2008-04-15 Kamada Ltd Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung
GB0524432D0 (en) * 2005-11-30 2006-01-11 Nhs Blood & Transplant Method
AU2007213344B2 (en) * 2006-02-09 2012-11-15 Kamada Ltd. Pulmonary delivery of alpha-I proteinase inhibitor
CA2694854C (en) 2007-08-17 2016-09-27 Csl Behring Gmbh Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i
CN102180966B (zh) * 2011-01-28 2013-04-03 哈尔滨派斯菲科生物制药股份有限公司 一种规模化生产人α1-抗胰蛋白酶的方法
US9421248B2 (en) 2011-12-30 2016-08-23 Grifols, S.A. Alpha 1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations
WO2017066683A1 (en) 2015-10-15 2017-04-20 Plasma Technologies, Llc Methods for extracting proteins from blood plasma
MX2018009331A (es) 2016-02-03 2018-11-09 Plasma Tech Llc Metodos para extraer proteinas a partir de un material a base de sangre.
US10815270B1 (en) 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (de) * 1962-01-03
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
US4100149A (en) * 1975-08-28 1978-07-11 Rhone-Poulenc Industries Method of separating proteins by ion exchange
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4656254A (en) * 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification

Also Published As

Publication number Publication date
JPH0764750B2 (ja) 1995-07-12
ES2051684T3 (es) 1994-07-01
DE3686470D1 (de) 1992-09-24
DE3686470T2 (de) 1993-01-21
EP0221426A3 (en) 1989-02-08
CA1286848C (en) 1991-07-23
JPS62108821A (ja) 1987-05-20
AU591397B2 (en) 1989-11-30
US4697003A (en) 1987-09-29
EP0221426A2 (de) 1987-05-13
AU6462486A (en) 1987-05-07
EP0221426B1 (de) 1992-08-19

Similar Documents

Publication Publication Date Title
ATE79633T1 (de) Verfahren zur herstellung des alpha-1-proteinase- inhibitors.
ATE200293T1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
DE3686475D1 (de) Verfahren zur herstellung des alpha-1-proteinase-inhibitors.
DE3484179D1 (de) Verfahren zur reinigung von faktor viii-c.
ATE302216T1 (de) Verfahren zur aufreinigung des faktors viii
ATE51104T1 (de) Verfahren zur abtrennung von metallen aus waessrigen medien.
DE69229068D1 (de) Verfahren zur Reinigung von menschlichem Albumin
ATE154033T1 (de) Verfahren zur reinigung von proteinen
ATE152116T1 (de) Schnellere methode für die reassoziation von nukleinsäure
ATE30844T1 (de) Verfahren zur herstellung der wichtigsten proteine des haemolysierten bluts in einer nichtdenaturierten form.
ATE347564T1 (de) Verfahren zur reinigung von hämoglobin
GB1496726A (en) Fractionation of proteins by electrical means
ATE6925T1 (de) Verfahren zur reinigung von gallium enthaltenden loesungen.
DE69029471D1 (de) Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin
ATE1865T1 (de) Verfahren zur reinigung von iso-alpha-saeuren aus hopfen.
FR2632302B1 (fr) Procede de recuperation d'acide citrique a partir d'une liqueur en contenant
SE8501170L (sv) Forfarande
ATE222925T1 (de) Verbessertes verfahren zur herstellung von faktor viii
ATE388722T1 (de) THERAPEUTISCHE FRAGMENTE DES ßVON WILLEBRANDß FAKTORS
FI1343809T4 (fi) Menetelmä alfa-1 proteinaasinestäjän valmistamiseksi
ATE26130T1 (de) Verfahren zur reinigung von lactulosesirup.
DE3764511D1 (de) Verfahren zur reinigung von carnitin.
DE3580007D1 (de) Verfahren zur reinigung von rohem beta-phenylethylalkohol.
PT77232A (fr) Procede pour la dissolution selective du plomb
ATE84504T1 (de) Verfahren zur abtrennung von kupfer aus basisch reagierenden, waessrigen loesungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EELA Cancelled due to lapse of time